Market Place
Sourcing Support
EuroAPI taps new CEO from within its ranks
10 Dec 2024 //
PRESS RELEASE
Olivier Falut appointed EUROAPI’s Chief Financial Officer
16 Oct 2024 //
PRESS RELEASE
EUROAPI closes the financing of its FOCUS-27 plan
15 Oct 2024 //
PRESS RELEASE
EUROAPI completes financing of FOCUS-27 plan and moves forward
11 Oct 2024 //
PRESS RELEASE
Moehs & EUROAPI Sign Agreement For Production Of Metamizole In EU
07 Oct 2024 //
PRESS RELEASE
Research article: Advancing Sustainability in Peptide Synthesis
03 Oct 2024 //
PRESS RELAESE
Aizon Unveils AI eBR Light Solution to Boost Manufacturing with Euroapi
18 Sep 2024 //
PRESS RELEASE
Availability of 2024 Half-Year Financial Report
05 Aug 2024 //
PRESS RELEASE
EUROAPI - Availability of 2024 Half-Year Financial Report
03 Aug 2024 //
GLOBENEWSWIRE
H1 2024 Results: Focus-27 Strategic Plan On Track
30 Jul 2024 //
GLOBENEWSWIRE
EUROAPI H1 2024 Results
30 Jul 2024 //
PRESS RELEASE
EuroAPI telegraphs 2 site sales, hundreds of layoffs
27 Jun 2024 //
FIERCE PHARMA
EUROAPI is moving ahead with its FOCUS-27 plan, setting the foundations for future profitable growth
26 Jun 2024 //
PRESS RELEASE
EUROAPI Moves Ahead With FOCUS-27 Plan For Growth
26 Jun 2024 //
PRESS RELEASE
EUROAPI and Priothera enter into CDMO collaboration to advance oncology project
18 Jun 2024 //
PRESS RELEASE
EUROAPI Reaches Major Health IPCEI Milestone
06 Jun 2024 //
PRESS RELEASE
Euroapi €130-150M Animal Contract: Health Presence Strengthening Supply Deal
23 May 2024 //
PRESS RELEASE
Combined General Meeting of May 22, 2024
22 May 2024 //
PRESS RELEASE
Evelyne Nguyen appointed EUROAPI`s Chief Financial Officer
13 May 2024 //
PRESS RELEASE
Combined General Meeting of May 22, 2024 - Availability of preparatory documents
30 Apr 2024 //
PRESS RELEASE
EUROAPI Streamlines Its Executive Committee to Improve Focus and Efficiency
09 Apr 2024 //
PRESS RELEASE
Availability of the 2023 Universal Registration Document, including the AFR
05 Apr 2024 //
PRESS RELEASE
2023 Universal Registration Document
28 Mar 2024 //
GLOBENEWSWIRE
Full-year 2024 guidance suspended due to the temporary pause of API production at the Brindisi site in Italy
15 Mar 2024 //
PRESS RELEASE
EuroAPI’s blueprint for ‘leaner’ operations includes dropping products
29 Feb 2024 //
ENDPTS
Full-year 2023 results
28 Feb 2024 //
PRESS RELEASE
EuroAPI taps new CEO as it embarks on restructuring campaign
28 Feb 2024 //
FIERCE PHARMA
EUROAPI R&D supports CDMO strategy through landmark white paper on enzyme production
11 Jan 2024 //
PRESS RELEASE
EUROAPI strengthens Executive Committee with of Ludwig de Mot as Exe.VP - CTO
04 Jan 2024 //
PRESS RELEASE
EUROAPI appoints new Executive Committee members
28 Nov 2023 //
PRESS RELEASE
CDMO: EUROAPI completes acquisition of Biano
21 Nov 2023 //
PRESS RELEASE
Fighting tuberculosis: EUROAPI’s rifampicin API meets new requirements for nitrosamine impurity standards
24 Oct 2023 //
PRESS RELEASE
EUROAPI increases the resources allocated to the liquidity contract with Kepler Cheuvreux
24 Oct 2023 //
PRESS RELEASE
Full-Year 2023 outlook revised downwards Launch of a strategic review Mid-term perspectives suspended
09 Oct 2023 //
PRESS RELEASE
EUROAPI to acquire BianoGMP to strengthen its CDMO expertise in the high-growth oligonucleotide market
30 Aug 2023 //
PRESS RELEASE
Availability of 2023 Half-Year Financial Report
02 Aug 2023 //
PRESS RELEASE
H1 2023 Results
01 Aug 2023 //
PRESS RELEASE
Ferring looks to scale up gene therapy; EuroAPI to boost production of pain medicine
15 Jun 2023 //
ENDPTS
Health Sovereignty: EUROAPI Supports the Supply of Essential Medicines to France and Europe
13 Jun 2023 //
BUSINESSWIRE
EUROAPI Invests €50M to Meet Growing Demand for Prostaglandins
07 Jun 2023 //
PRESS RELEASE
EUROAPI’s Board of Directors proposes Géraldine Leveau as Director
10 May 2023 //
PRESS RELEASE
EUROAPI and Novéal sign CDMO agreement to advance cosmetic projects
09 May 2023 //
PRESS RELEASE
EUROAPI announces new, global R&D structure to accelerate innovation in CDMO and API Solutions
02 May 2023 //
PRESS RELEASE
Availability of the Amendment n°1 of the 2022 Universal Registration Document
26 Apr 2023 //
PRESS RELEASE
EUROAPI- Full-Year 2022 Results
08 Mar 2023 //
PRESS RELEASE
CDMO: EUROAPI launches a new spray dryer in Haverhill to support clients with molecule development
20 Feb 2023 //
PRESS RELEASE
Euroapi restarts prostaglandin production in Budapest
01 Feb 2023 //
FIERCE PHARMA
EUROAPI’s Board of Directors proposes Mattias Perjos as independent Director
11 Jan 2023 //
PRESS RELEASE
EUROAPI 2022 Half-year results
09 Jan 2023 //
PRESS RELEASE
Vitamin B12: EUROAPI to invest €40 million for a more efficient and sustainable production process in France
09 Jan 2023 //
PRESS RELEASE
EUROAPI updates its 2022 financial guidance
07 Dec 2022 //
PRESS RELEASE
Sanofi`s new drug ingredients spinoff EuroAPI drops sales guidance to €980M after Hungarian manufacturing flub
07 Dec 2022 //
FIERCE PHARMA
Terumo Pharmaceutical Solutions expanding CDMO reach outside Japan; EUROAPI
03 Nov 2022 //
ENDPTS
EUROAPI to Reach 500 kg Peptide and Oligonucleotide Capacity Per Year in Frankfurt by 2025
01 Nov 2022 //
BUSINESSWIRE
ESG: EUROAPI becomes a signatory to the United Nations Global Compact and the Global Responsible Care® Charter
20 Oct 2022 //
PRESS RELEASE
Ensuring API Supply Capacities for Europe and Beyond
13 Oct 2022 //
CHEMANAGER
EUROAPI 2022 Half-year results
01 Sep 2022 //
PRESS RELEASE
